[Trial of an alpha-blocking agent in the treatment of thyrotoxicosis].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D004873:Ergolines / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy*; D009539:Nicotinic Acids / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D004873:Ergolines; D009539:Nicotinic Acids
Sperimentazione di un farmaco alfa bloccante nel trattamento della tirotossicosi